ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03025
-0,01%
Bitcoin
103.424,20
-0,67%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Praxis Precision Medicines Inc (PRAX)

  7. Praxis Precision Medicines Inc (PRAX) News

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRAX
DatumZeitQuelleÜberschriftSymbolFirma
15/01/202500h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
15/01/202500h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
15/01/202500h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
15/01/202500h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
09/01/202501h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
09/01/202501h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
09/01/202501h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
23/12/202422h13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PRAXPraxis Precision Medicines Inc
20/11/202403h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
20/11/202403h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202403h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202423h50Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202420h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
14/11/202419h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
08/11/202420h17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202413h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
06/11/202413h57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
22/10/202421h24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PRAXPraxis Precision Medicines Inc
15/10/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
26/09/202414h00GlobeNewswire Inc.Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International CongressNASDAQ:PRAXPraxis Precision Medicines Inc
03/09/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
13/08/202413h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
13/08/202413h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
01/08/202403h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
01/08/202403h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
01/08/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
01/08/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:PRAX

Kürzlich von Ihnen besucht

NASDAQ
TKNO
Alpha Teknova
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten